FOLD AMICUS THERAPEUTICS, INC.: institutional ownership and insider trading
23 funds reported holding $566M of AMICUS THERAPEUTICS, INC. in their latest 13F filings; in Q2 2026 funds net sold $4.71B, with 0 new positions and 292 funds selling out; over the last 12 months insiders bought $0 and sold $5.42M on the open market.
Largest institutional holders of FOLD
- VANGUARD GROUP INC — $423M
- KRYGER CAPITAL Ltd — $42.6M
- Nuveen Asset Management, LLC — $35.9M
- CIBRA Capital Ltd — $24.4M
- JANUS HENDERSON GROUP PLC (JHG) — $15.5M
- Ion Asset Management Ltd. — $6.87M
- Cubist Systematic Strategies, LLC — $6.79M
- Kodai Capital Management LP — $4.94M
- ANGELO GORDON & CO., L.P. — $1.42M
- Mesirow Institutional Investment Management, Inc. — $842K
Recent FOLD insider trades
- Mar 2, 2026: Campbell Bradley L sold 22,500 shares ($323K)
- Jan 20, 2026: Campbell Bradley L sold 75,000 shares ($1.07M)
- Dec 19, 2025: Clark David Michael sold 25,642 shares ($363K)
- Dec 15, 2025: Clark David Michael sold 25,643 shares ($282K)
5%+ owners
- Barclays PLC: 5.7% (Schedule 13G, filed May 14, 2026)
- UBS Group AG: 5.5% (Schedule 13G, filed May 7, 2026)
- Vanguard Capital Management: 5.2% (Schedule 13G, filed Apr 29, 2026)